XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 141 participants.
Also called NCT05881278
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 141 participants
- Sponsor
- XVIVO Perfusion
- Registry
-
NCT05881278
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05881278. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-10 (actual); primary completion 2025-11-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
- Condition
- Heart Failure
- Condition
- Transplant; Failure, Heart
- Intervention (Device)
- Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS)
- Lead sponsor
- XVIVO Perfusion
Record details
- Record id
cardio:ct-nct05881278- Content hash
d02b83e872ab3c3259c400d340e53938bdba67843b5cc0ae71c3d67934dca689